OOB

Drug-Eluting Percutaneous Transluminal Coronary Angioplasty Catheter

Product code
OOB
Device name
Drug-Eluting Percutaneous Transluminal Coronary Angioplasty Catheter
Device class
Class 3
Medical specialty
Unknown
Marketing pathway
PMA

FDA classification definition

A drug-eluting percutaneous transluminal coronary angioplasty catheter is a combination product intended for balloon dilatation of a hemodynamically significant coronary artery or bypass graft stenosis in patients evidencing coronary ischemia for the purpose of improving myocardial perfusion. A drug-eluting ptca catheter may also be intended for the treatment of acute myocardial infarction; Treatment of in-stent restenosis (isr) and/or post-deployment stent expansion. A drug-eluting ptca catheter delivers a drug to the vessel as part of the angioplasty procedure, which is intended to inhibit restenosis.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: OOB
Classification and pathway per current FDA publications. Data from openFDA (CC0).